ARCHIVES

FDA Selects 23 Survivors To Review Drug Applications.

This article is from The Cancer Letter archive.

Vol. 27 No. 24 | June 15, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Albert and Mary Lasker Foundation announce 2014 award winners

September 12, 2014

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

16 Institutions Win NCI Awards for Phase I Trials

May 2, 2003

California Land Control Grant, Need Administrator

April 21, 1978

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December

September 19, 2014